THE CHARACTERISTICS AND PROGNOSIS OF HEART FAILURE ASSOCIATED WITH CHEMOTHERAPY FOR EARLY BREAST CANCER: A POPULATION-BASED MATCHED COHORT STUDY

2021 ◽  
Vol 37 (10) ◽  
pp. S59-S60
Author(s):  
H Abdel-qadir ◽  
F Tai ◽  
R Croxford ◽  
P Austin ◽  
E Amir ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Heart Failure ◽  
Cohort Study ◽  
Early Breast Cancer ◽  
Population Based ◽  
Matched Cohort ◽  
Matched Cohort Study

PROGNOSIS OF HEART FAILURE FOLLOWING CARDIOTOXIC BREAST CANCER CHEMOTHERAPY: A RETROSPECTIVE MATCHED COHORT STUDY

2020 ◽  
Vol 75 (11) ◽  
pp. 708
Author(s):  
Felicia Tai ◽  
Ruth Croxford ◽  
Peter Austin ◽  
Eitan Amir ◽  
Oscar Calvillo Argüelles ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Heart Failure ◽  
Cohort Study ◽  
Cancer Chemotherapy ◽  
Matched Cohort ◽  
Breast Cancer Chemotherapy ◽  
Matched Cohort Study

Insomnia But Not Hypnotics Use Associates with the Risk of Breast Cancer: A Population-Based Matched Cohort Study

2018 ◽  
Vol 27 (10) ◽  
pp. 1250-1256 ◽  
Author(s):  
Hsiao-Yean Chiu ◽  
Chun-Jen Huang ◽  
Yen-Chun Fan ◽  
Pei-Shan Tsai
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Population Based ◽  
Matched Cohort ◽  
Matched Cohort Study

scholarly journals Nonsteroidal Anti-Inflammatory Drugs Reduce Second Cancer Risk in Patients With Breast Cancer: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan

2021 ◽  
Vol 11 ◽  
Author(s):  
Yin-Che Lu ◽  
Pin-Tzu Chen ◽  
Mei-Chen Lin ◽  
Che-Chen Lin ◽  
Shi-Heng Wang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Propensity Score ◽  
Cancer Risk ◽  
Population Based ◽  
Matched Cohort ◽  
Second Cancer ◽  
Matched Cohort Study ◽  
Inflammatory Drugs ◽  
Second Cancer Risk

Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce mortality in patients with cancer, especially breast cancer, but their influence on second cancer risk is uncertain. This study aimed to examine whether NSAID use is associated with second cancer risk in patients with breast cancer. This population-based propensity score-matched cohort study using Taiwan’s National Health Insurance Research Database enrolled patients with newly diagnosed breast cancer (n = 7356) with and without (n = 1839) NSAID therapy from 2000 to 2009. They were followed up until the diagnosis of second cancer, death, or end of 2011. Cox proportional hazard models were used to estimate adjusted hazard ratios (aHR). The NSAID cohort had a lower incidence rate of second cancer than the non-NSAID cohort (5.57 vs. 9.19 per 1,000 person-years), with an aHR of 0.63 (95% confidence interval (CI) 0.46–0.87). When compared with the non-NSAID cohort, the second cancer incidence was lower in patients taking non-cyclooxygenase 2 inhibitors (aHR 0.67, 95% CI 0.47–0.94) and in those receiving multiple NSAIDs during follow-up (aHR 0.55, 95% CI 0.37–0.84). A dose–response relationship existed in NSAID cumulative days. The findings demonstrate that NSAID use reduces second cancer risk in a dose-dependent manner in patients with primary breast cancer.

Sickness absence and disability pension following breast cancer – A population-based matched cohort study

The Breast ◽  
2014 ◽  
Vol 23 (6) ◽  
pp. 844-851 ◽  
Author(s):  
Marie Høyer Lundh ◽  
Claudia Lampic ◽  
Karin Nordin ◽  
Johan Ahlgren ◽  
Leif Bergkvist ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Sickness Absence ◽  
Disability Pension ◽  
Population Based ◽  
Matched Cohort ◽  
Matched Cohort Study

Congestive heart failure among children with acute leukemia: a population-based matched cohort study

2018 ◽  
Vol 60 (2) ◽  
pp. 385-394 ◽  
Author(s):  
Deepak Chellapandian ◽  
Jason D. Pole ◽  
Paul C. Nathan ◽  
Lillian Sung
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Cohort Study ◽  
Acute Leukemia ◽  
Population Based ◽  
Matched Cohort ◽  
Matched Cohort Study
Sign in / Sign up

Export Citation Format

Share Document